Cargando…
Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
Diagnosis of Parkinson’ disease (PD) carries a high misdiagnosis rate due to failure to recognize atypical parkinsonian disorders (APD). Usually by the time of diagnosis greater than 60% of the neurons in the substantia nigra are dead. Therefore, early detection would be beneficial so that therapeut...
Autores principales: | Potashkin, Judith A., Santiago, Jose A., Ravina, Bernard M., Watts, Arthur, Leontovich, Alexey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428307/ https://www.ncbi.nlm.nih.gov/pubmed/22952715 http://dx.doi.org/10.1371/journal.pone.0043595 |
Ejemplares similares
-
Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
por: Wang, Zhibin, et al.
Publicado: (2016) -
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020) -
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018) -
Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2014) -
Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
por: Santiago, Jose A., et al.
Publicado: (2015)